The trademark IZINOSE was filed by TEVA Pharmaceuticals Europe B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on September 13, 2021, and received one opposition filed on December 8, 2021 by Ipsen Consumer HealthCare on Likelihood of confusion. the opponent was represented by Bernard-Boyle, Hélène and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 8, 2021
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).